Seegene Supplies Diagnostic Reagents Worth 45 Million Euros to Italian Regional Government

Seegene CI (Photo by Seegene)

[Asia Economy Reporter Chunhee Lee] Seegene announced on the 18th that it has successfully won a bid for a diagnostic reagent supply contract worth 45 million euros (approximately 62.5 billion KRW) with the Tuscany regional government in Italy.

Seegene stated that its local subsidiary in Italy, 'Arrow Diagnostics,' was selected as a supplier in the diagnostic reagent bidding conducted every five years by the Tuscany regional government. The scale of this supply has increased more than sixfold from about 10 billion KRW in 2016. A Seegene official explained, "It is analyzed that the demand for diagnostic reagents has increased as the utilization of molecular diagnostics was experienced firsthand in medical settings such as hospitals during the COVID-19 pandemic response."

Accordingly, starting from January next year, Seegene will supply COVID-19 diagnostic reagents along with diagnostic reagents for human papillomavirus (HPV), sexually transmitted infections (STI), drug resistance testing (Entero DR), and tuberculosis (MTB) to 13 public hospitals in Tuscany. Notably, 57% of the contracted supply volume consists of COVID-19 diagnostic reagents, while 43% includes non-COVID-19 diagnostic reagents such as HPV.

Regarding the success in this bid, the company explained that factors such as multiplex technology and the automation of the entire analysis process from extraction to result derivation were reflected. They also evaluated that their contribution to Italy's COVID-19 overcoming process, including supplying about 7.15 million doses of COVID-19 diagnostic reagents to the COVID-19 emergency response committee under the Italian Ministry of Defense in April last year, played a role. Italy also accounts for the largest portion of Seegene's overseas sales by country.

Franco Maceroni, head of Seegene's Italian subsidiary, said, "We expect that this contract signing will have a positive impact on winning bids in other regions of Italy in the future and serve as a foundation for the continuous growth of sales of non-COVID-19 products."

This content was produced with the assistance of AI translation services.